Raymond James & Associates’s Progyny PGNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$251K Sell
14,974
-52,188
-78% -$1.25M ﹤0.01% 3504
2024
Q2
$1.92M Sell
67,162
-2,692
-4% -$81.1K ﹤0.01% 2194
2024
Q1
$2.66M Buy
69,854
+13,102
+23% +$495K ﹤0.01% 1985
2023
Q4
$2.11M Sell
56,752
-16,301
-22% -$547K ﹤0.01% 2069
2023
Q3
$2.49M Sell
73,053
-9,260
-11% -$350K ﹤0.01% 1884
2023
Q2
$3.24M Sell
82,313
-12
-0% -$433 ﹤0.01% 1772
2023
Q1
$2.64M Buy
82,325
+102
+0.1% +$3.37K ﹤0.01% 1867
2022
Q4
$2.56M Buy
82,223
+12,862
+19% +$465K ﹤0.01% 1838
2022
Q3
$2.57M Buy
69,361
+857
+1% +$32.1K ﹤0.01% 1812
2022
Q2
$1.99M Sell
68,504
-3,716
-5% -$133K ﹤0.01% 1988
2022
Q1
$3.71M Buy
72,220
+15,432
+27% +$661K ﹤0.01% 1728
2021
Q4
$2.86M Sell
56,788
-843
-1% -$47.2K ﹤0.01% 1922
2021
Q3
$3.23M Sell
57,631
-27,001
-32% -$1.49M ﹤0.01% 1767
2021
Q2
$4.99M Buy
84,632
+37,188
+78% +$2.09M ﹤0.01% 1489
2021
Q1
$2.11M Buy
47,444
+30,886
+187% +$1.44M ﹤0.01% 1970
2020
Q4
$702K Buy
16,558
+5,597
+51% +$182K ﹤0.01% 2578
2020
Q3
$323K Buy
10,961
+2,747
+33% +$75.7K ﹤0.01% 2908
2020
Q2
$212K Buy
+8,214
New +$189K ﹤0.01% 3093
2020
Q1
Sell
-7,532
Closed -$207K 3671
2019
Q4
$207K Buy
+7,532
New +$181K ﹤0.01% 3328

Other funds holding PGNY

Raymond James & Associates's PGNY Position: Q3 2024 in Review

Raymond James & Associates reduced its Progyny (PGNY) stake by 78% in Q3 2024, selling an estimated $1.25M and leaving 14,974 shares worth $251K. The position accounts for ﹤0.01% of the portfolio, ranked #3504.

Raymond James & Associates first reported a position in PGNY in Q4 2019 and has held it in 19 quarters since. The position peaked at $4.99M in Q2 2021. 285 funds tracked by Wall St. Rank hold PGNY as of Q3 2024.

  • Raymond James & Associates held 14,974 shares of Progyny worth $251K as of Q3 2024.
  • Raymond James & Associates sold 52,188 Progyny shares in Q3 2024, an estimated $1.25M.
  • Progyny made up ﹤0.01% of Raymond James & Associates's portfolio in Q3 2024, its #3504 holding.
  • Raymond James & Associates first reported a position in Progyny in Q4 2019 and has held it in 19 quarters since.
  • Raymond James & Associates's Progyny position peaked at $4.99M in Q2 2021.
  • 285 funds tracked by Wall St. Rank held Progyny as of Q3 2024.

Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.